Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Smith

Showing results (531-540 of 594) with videos related to

Pageof 60
Sort By:
AEM Education and Training|October 7, 2021
Defining "county": A mixed-methods inquiry of county emergency medicine residency programsJennie A Buchanan, Maria Moreira, Taku Taira, et al.
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2024
Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196Stéphane De Wit, Fabrice Bonnet, Olayemi Osiyemi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Journal of Clinical Pharmacology|September 8, 2018
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV-1-Infected SubjectsManoli Vourvahis, Lynn McFadyen, Sunil Nepal, et al.
Physiology (Bethesda, Md.)|October 11, 2018
Loss of Ovarian Hormones and Accelerated Somatic and Mental AgingWalter A Rocca, Liliana Gazzuola Rocca, Carin Y Smith, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Cell Reports|August 3, 2016
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeKimberly A Dowd, Christina R DeMaso, Rebecca S Pelc, et al.
Neurology|September 3, 2013
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis opticaYujuan Jiao, James P Fryer, Vanda A Lennon, et al.
Pageof 60

Showing results (531-540 of 594) with videos related to

Sort By:
Pageof 60
AEM Education and Training|October 7, 2021
Defining "county": A mixed-methods inquiry of county emergency medicine residency programsJennie A Buchanan, Maria Moreira, Taku Taira, et al.
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2024
Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196Stéphane De Wit, Fabrice Bonnet, Olayemi Osiyemi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Journal of Clinical Pharmacology|September 8, 2018
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV-1-Infected SubjectsManoli Vourvahis, Lynn McFadyen, Sunil Nepal, et al.
Physiology (Bethesda, Md.)|October 11, 2018
Loss of Ovarian Hormones and Accelerated Somatic and Mental AgingWalter A Rocca, Liliana Gazzuola Rocca, Carin Y Smith, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Cell Reports|August 3, 2016
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeKimberly A Dowd, Christina R DeMaso, Rebecca S Pelc, et al.
Neurology|September 3, 2013
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis opticaYujuan Jiao, James P Fryer, Vanda A Lennon, et al.
Pageof 60